- Home
- MLTX vs NFJ Comparison
MLTX vs NFJ Comparison
Compare MLTX & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLTX | NFJ |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2020 | 2003 |
Fundamental Metrics
Financial Performance| Metric | MLTX | NFJ |
|---|---|---|
| Price | $10.87 | $14.49 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $28.54 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 296.1K |
| Earning Date | 11-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.01% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.80 | $12.25 |
| 52 Week High | $23.29 | $15.75 |
Technical Indicators
Market Signals| Indicator | MLTX | NFJ |
|---|---|---|
| Relative Strength Index (RSI) | 26.48 | 27.77 |
| Support Level | N/A | $14.16 |
| Resistance Level | $19.24 | $14.69 |
| Average True Range (ATR) | 0.61 | 0.20 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 5.37 | 6.01 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. It pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.